New COVID-19 Variant EG.5: WHO Warns While Reassuring
With news circulating about the new COVID-19 variant EG.5, also known as Eris, people are increasingly concerned about its nature, risks, and impact on health.
What is EG.5?
EG.5 is a subvariant of the well-known Omicron variant, first detected in China in February 2023. This variant is characterized by its ability to evade antibodies formed by the body against previous variants, explaining the recent rise in cases.
Does EG.5 Pose a Significant Threat?
So far, the World Health Organization (WHO) indicates that the public health risks of EG.5 are low, based on available data.
What are the Symptoms of EG.5?
The symptoms of EG.5 do not differ significantly from those of other COVID-19 variants and include:
- Fever
- Persistent cough
- Fatigue
- Runny nose
- Sore throat
- Loss of taste and smell
Who is Most at Risk of EG.5?
While EG.5 does not appear to pose a major public health threat, it could pose a higher risk to certain groups, such as:
- Older adults
- Individuals with chronic health conditions
- Immunocompromised individuals
What are the Preventive Measures for EG.5?
COVID-19 preventive measures remain effective against EG.5, including:
- Getting vaccinated against COVID-19
- Wearing masks in crowded spaces
- Maintaining a safe distance from others
- Washing hands frequently
- Staying home when sick
EG.5 is a new strain of COVID-19, but the WHO reassures that its risks are low. However, everyone should continue to follow preventive measures to reduce the spread of the virus and protect themselves and others.
